AzTrials
AzTrials

Twin Pregnancy, Antepartum Condition or ComplicationFITNCT05773677

Diet in Twin Pregnancy: the Wellness of Mother and Babies.

A study testing Specific Diet in people with Twin Pregnancy, Antepartum Condition or Complication and Gestational Diabetes, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to evaluate how variations in maternal nutrition may affect twin pregnancy and in particular: incidence of maternal obstetric complications: gestational diabetes gestational hypertension or preeclampsia intrahepatic cholestasis (ICP) fetal growth, development and birth weight of the babies Read more about this study

Who is it for?
Ages 18 to 40 years, women onlyHealthy volunteers can take part
What is being tested?
Specific Diet
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteItaly
Study dates
10 Oct 2022to Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • dichorionic-diamniotic twin pregnancies
  • monochorionic-diamniotic twin pregrancies
  • monochorionic- monoamniotic twin pregnancies
  • spontaneous onset or by homologous PMA techniques
  • Age between 18 and 40 years
  • Gestational age between 8 weeks+0 days and 25 weeks+6 days

Who cannot join

  • Pregestational diabetes mellitus (type I and II)
  • Chronic hypertension
  • Previous bariatric surgery
  • Chronic gastrointestinal disease (Celiac disease, Crohn's disease, Ulcerative Rectocolitis)
  • Age less than 18 years or more than 40 years
  • Gestational age less than 8 weeks or more than 26 weeks
Show all 11Show fewer
  • Fetal structural and/or genetic abnormalities
  • Heterologous PMA
  • Maternal eating disorders
  • Drug and/or alcohol use
  • Multiple pregnancies with more than two babies

Trial locations and contacts

1 site in 1 country.

Italy1 site, 1 recruiting
  • FPGemelliIRCCS

    Roma, 00168

    Daniela Visconti, MD, +393397316686, daniela.visconti@policlinicogemelli.it

    Ludovica Puri, MD

    Recruiting

Other trials in Italy

About this study

Official title: FIT: Food in Twins. Diet in Twin Pregnancy: the Wellness of Mother and Babies.

The aim of this study is to evaluate how variations in maternal nutrition may affect twin pregnancy and in particular:

  • incidence of maternal obstetric complications:
  • gestational diabetes
  • gestational hypertension or preeclampsia
  • intrahepatic cholestasis (ICP)
  • fetal growth, development and birth weight of the babies
Read the detailed description

Study design

At the time of recruitment, each patient will perform an initial clinical nutrition examination, during which will be evaluated, on the basis of BMI and specific anthropometric parameters, the necessary nutritional intake.

Patients included in the study will then be classified, on the basis of pre-pregnancy BMI, into 2 classes:

  • normal weight (BMI 18-25)
  • overweight (BMI 25-30) A specific diet will be developed for each patient, which will also take into account any food allergies or intolerances.

Each diet will be then eventually modified and revised throughout the pregnancy, according to the evolution of the same.

Patients will then continue their regular obstetrical examinations at the Obstetrical Day Hospital, every 4 weeks in case of uncomplicated dichorionic twin pregnancy and every 2 weeks in case of uncomplicated monochorionic twin pregnancy.

Once a month, in coincidence with the appointment at the Obstetric Day Hospital, the enrolled patients will be evaluated by the dedicated team of nutritionists.

Being tested
Specific Diet
Medical subject headings
Diabetes, Gestational, Hypertension, Pregnancy-Induced, Intrahepatic Cholestasis of Pregnancy, Feeding Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Specific DietDietary supplement

    A specific diet will be developed for each patient, which will also take into account any food allergies or intolerances.

    Each diet will be then eventually modified and revised throughout the pregnancy, according to the evolution of the same.

Study groups in NCT05773677
Study groupRoleWhat they receive
Case Group: with dietExperimentalPrescription of specific diet in pregnancy
Receives: Dietary Supplement: Specific Diet
Control Group: no dietNo interventionRetrospective group with no diet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. incidence of maternal obstetric complications:

    • gestational diabetes
    • gestational hypertension or preeclampsia -intrahepatic cholestasis (ICP)

    Measured: From enrollment in the study to delivery

Secondary outcomes (3)
  1. fetal growth and birth weight of the babies

    estimated fetal weight and actual fetal weight at delivery (expressed in grams)

    Measured: From enrollment in the study to delivery

  2. maternal weight gain

    expressed in kilograms

    Measured: From enrollment in the study to delivery

  3. differences in early or late enrollment of patients

    advantage of early enrollment in reducing the incidence of the above complications (expressed as percentage)

    Measured: From enrollment in the study to delivery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Mar 2023
  2. Study start10 Oct 2022
  3. Primary completionOct 2023 (estimated)
  4. Study completionApr 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Case group: prospective Control group: retrospective
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05773677
Sponsor's protocol ID
5078
Acronym
FIT
Status last verified
Mar 2023
First submitted
24 Feb 2023
Last updated
20 Mar 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Specific Diet in people with Twin Pregnancy, Antepartum Condition or Complication and Gestational Diabetes, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

incidence of maternal obstetric complications: (time frame: From enrollment in the study to delivery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in